Is Crohn’s Disease Fatal? Understanding Complications and Life Expectancy

Crohn’s disease can be serious, but it is not considered fatal. However, there is the potential for severe or even life-threatening complications when not managed effectively. Crohn’s disease is a form of inflammatory bowel disease (IBD) which currently has no cure.

Life expectancy depends on age at diagnosis, symptom severity, and treatment. A recent study has shown that people with IBD are no more likely to die than people without IBD, but the disease has known risks. Managing symptoms, living a healthy lifestyle, and getting regular check-ups may help reduce the risk of complications.

Two healthcare providers consult in a hospital hallway

shapecharge / Getty Images

Can You Die From Crohn’s Disease?

Crohn’s disease isn’t usually thought of as being a fatal disease. It’s considered to be a chronic condition—one that lasts a long time and needs regular management.

However, Crohn’s disease can be quite serious in some people. It can cause complications that might be life-threatening. People with Crohn’s disease may need to have treatments like surgery, which carry their own risk. Whether or not Crohn’s plays a small or a large role in a person’s death can be difficult to determine.

The thought of having a disease that could be fatal can be upsetting and could lead to difficult emotions. People with chronic conditions like Crohn’s may want to take care to address their mental and physical health.

Currently, the best way to avoid potential complications is to see a healthcare provider regularly and to treat the inflammation caused by Crohn’s disease as well as possible.

Life Expectancy With IBD

IBD may affect life expectancy. A study published in 2020 showed that life expectancy in people with IBD has been increasing in recent decades. However, it was still slightly lower than it is for people who don't live with a form of IBD.

A 2023 study showed that people with IBD are no more likely to die than people who don't live with the disease. However, it noted that people with Crohn's disease and their healthcare providers should be aware of associated risks such as cardiovascular disease and infections.

Factors That Affect Crohn’s Disease Life Expectancy

A 2022 study from Sweden found that, over 10 years, people with Crohn’s had the same mortality as the general population. However, some things affected mortality.

The study found:

  • Survival was lower for people diagnosed before 1985.
  • Older females had a greater mortality (especially when diagnosed before 1985).
  • Having a colon disease and complications like stricture (narrowing of the colon) may also play a role, but the connection was not strong.

Do People With Crohn’s Disease Live Normal Lives?

With improvements in understanding and treating Crohn’s disease, people with this condition live a better quality of life than in previous decades. However, when the disease is active (causing a flare-up), it can reduce the quality of life. It was also shown that quality of life improved over time, possibly because adjusting to the disease is helpful. 

Crohn's Disease

Life-Threatening Complications of Crohn’s

Some conditions associated with Crohn’s disease increase the risk of a life-threatening complication. People concerned about these related conditions should discuss their risk with a healthcare provider because it is not the same for everyone with Crohn’s disease.

Colorectal Cancer

People with Crohn's disease affecting the colon are at an increased risk for colorectal cancer. It is a major cause of mortality in people with IBD. One study showed that it may be responsible for the deaths of 10% to 15% of people with IBD.

Colorectal Cancer

Everyone's risk of colorectal cancer is going to be different. The risk increases the longer a person has had Crohn's disease and if there is inflammation in the colon.

Intestinal Obstruction

An obstruction happens when the bowel is blocked and stool can’t move through it. Obstructions are more common in people with IBD than in the general population. This can be due to inflammation, which causes the bowel tissue to swell. It can also happen when scar tissue forms from the inflammation, causing ulcers and then healing.

Obstructions may be treated with surgery, usually a resection to remove the narrowed part of the bowel. There is not enough data about how often surgery for an obstruction can lead to a poor outcome. One study showed that 7% of people who had surgery for obstruction had a severe complication.

Older studies show that the mortality rate can be higher with an emergency surgery, as opposed to a scheduled one. However, there were no deaths in a study examining operations on 61 people from 2013 to 2017.

Fistulas

One of the complications that can lead to lowered quality of life and the need for more treatments is a fistula. A fistula is an abnormal channel that is created between two organs or an organ and the skin. About 12% of people with Crohn’s live with a fistula.

Fistula of the Intestines

Unfortunately, having a fistula may be associated with other conditions that have a higher risk of mortality. It’s rare, but one study showed that unmanaged Crohn’s disease was thought to be the biggest factor leading to a risk of death.

A 2022 study of people in the United States who were hospitalized to treat a fistula showed a decrease in deaths between 2009 and 2019. This was true even though there was an increase in people being admitted to the hospital during that time.

Perforated Colon

Perforations are a risk for every form of IBD. However, they are rare, occurring in 1% to 3% of people with Crohn’s disease. However, they are an emergency, and they can be life-threatening.

It's thought that chronic inflammation weakens the intestinal wall and allows bacteria into the abdomen. This is called peritonitis (inflammation of the abdominal lining, or peritoneum) which can lead to potentially life-threatening conditions like shock or sepsis. However, there is no good data on how often complications from perforation lead to poor outcomes, including death.

Toxic Megacolon

Toxic megacolon is a rare complication of IBD in the large intestine where the colon expands rapidly, and rupture is a risk. This is potentially life-threatening. Studies report different rates, but it is generally thought to occur more frequently in ulcerative colitis than in Crohn’s disease.

Toxic megacolon is usually treated with surgery. Mortality after toxic megacolon was high decades ago but is now thought to be between 0% and 2%.

Adverse Effects of Medication

Some medications that are used to treat Crohn’s disease may also carry a risk of serious side effects. Steroids, which are commonly used for treating flare-ups, can put people at risk for infections.

Anti-tumor necrosis factor (TNF) medications, such as Humira (adalimumab) may be used for long-term maintenance but may increase the risk of infection, especially tuberculosis. Asacol (mesalamine) and anti-TNF drugs may also contribute to a worsening of heart failure.

Thiopurines such as Azasan (azathioprine) are immunosuppressive medications and can increase the risk of viral infections (including cytomegalovirus), nonmelanoma skin cancers, and lymphoma.

The risks of medications will be different for each person. There are a variety of treatments for IBD, so if one drug carries too much risk, there are other options. Crohn's disease must be treated because the inflammation it causes could lead to serious complications.

When to See a Healthcare Provider for Complications

People with Crohn’s disease need regular management of their condition. This means seeing a healthcare provider (commonly a gastroenterologist) on a regular basis for treatment and to prevent potential complications.

It’s important to consult with your healthcare provider about any new symptoms or if existing symptoms worsen.

These are some symptoms that are a reason to see a healthcare provider:

However, people with IBD should reach out to a healthcare provider whenever they have a concern. It’s better to find out symptoms are not serious rather than waiting until they become an emergency.

Stages of Crohn's Disease

Crohn's disease goes through periods of active disease and remission. It is generally considered a progressive disease, meaning that it may cause more complications over time. However, treating it soon after diagnosis with effective medications may help lower the risk of complications and improve long-term outcomes.

Summary

Crohn’s disease is a chronic inflammatory condition that can affect many parts of the body, but it's not considered fatal. People with any form of IBD may have a slightly shorter average lifespan than those without it. However, life expectancy depends on age at diagnosis, symptom severity, and treatment.

Life-threatening complications from Crohn’s disease are not common. Maintaining your treatment plan, regular check-ups, a healthy lifestyle, and avoiding triggers, may help manage your condition and prevent complications. It's important to consult with your healthcare provider regarding any new or worsening symptoms.

21 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Follin-Arbelet B, Cvancarova Småstuen M, Hovde Ø, Jelsness-Jørgensen LP, Moum B. Mortality in patients with inflammatory bowel disease: results from 30 years of follow-up in a Norwegian inception cohort (The IBSEN study). J Crohns Colitis. 2023;17:497-503. doi:10.1093/ecco-jcc/jjac156

  2. Kuenzig ME, Manuel DG, Donelle J, Benchimol EI. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease. CMAJ. 2020;192:E1394-E1402. doi:10.1503/cmaj.190976.

  3. Follin-Arbelet B, Cvancarova Småstuen M, Hovde Ø, Jelsness-Jørgensen LP, Moum B. Mortality in patients with inflammatory bowel disease: results from 30 years of follow-up in a Norwegian inception cohort (The IBSEN study). J Crohns Colitis. 2023;17:497-503. doi:10.1093/ecco-jcc/jjac156

  4. Zhulina Y, Udumyan R, Tysk C, Halfvarson J. Mortality in patients with Crohn's disease in Örebro, Sweden 1963-2010. Scand J Gastroenterol. 2022;57:158-164. doi:10.1080/00365521.2021.1991466

  5. Zhulina Y, Udumyan R, Tysk C, Halfvarson J. Mortality in patients with Crohn's disease in Örebro, Sweden 1963-2010. Scand J Gastroenterol. 2022;57:158-164. doi:10.1080/00365521.2021.1991466

  6. Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II. Inflamm Bowel Dis. 2018;24(5):966-976. doi:10.1093/ibd/izy015

  7. Keller DS, Windsor A, Cohen R, Chand M. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol. 2019;23:3-13. doi:10.1007/s10151-019-1926-2

  8. Goldstone RN, Steinhagen RM. Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am. 2019;99:1141-1150. doi:10.1016/j.suc.2019.08.007

  9. Fahim M, Dijksman LM, van Kessel CS, et al. Promising results of a new treatment in patients with bowel obstruction in colorectal surgery. Eur J Surg Oncol. 2020;46:415-419. doi:10.1016/j.ejso.2019.10.011

  10. Feroz SH, Ahmed A, Muralidharan A, Thirunavukarasu P. Comparison of the efficacy of the various treatment modalities in the management of perianal Crohn’s fistula: a review. Cureus. 2020;12:e11882. doi:10.7759/cureus.11882

  11. Mak WY, Mak OS, Lee CK, et al. Significant medical and surgical morbidity in perianal Crohn’s disease: results from a territory-wide study. J Crohns Colitis. 2018;12:1392-1398. doi:10.1093/ecco-jcc/jjy120

  12. Ali H, Ishtiaq R, Hanif MW, et al. Crohn’s disease with fistula: 10 year trends and mortality in the United States. Korean J Gastroenterol. 2022;80:142-148. doi:10.4166/kjg.2022.061

  13. Pouli S, Kozana A, Papakitsou I, Daskalogiannaki M, Raissaki M. Gastrointestinal perforation: clinical and MDCT clues for identification of aetiology. Insights Imaging. 2020;11:31. doi:10.1186/s13244-019-0823-6

  14. Pouli S, Kozana A, Papakitsou I, Daskalogiannaki M, Raissaki M. Gastrointestinal perforation: clinical and MDCT clues for identification of aetiology. Insights Imaging. 2020;11:31. doi:10.1186/s13244-019-0823-6

  15. Desai J, Elnaggar M, Hanfy AA, Doshi R. Toxic megacolon: background, pathophysiology, management challenges and solutions. Clin Exp Gastroenterol. 2020;13:203-210. doi:10.2147/CEG.S200760

  16. Beaugerie L, Rahier JF, Kirchgesner J. Predicting, preventing, and managing treatment-related complications in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2020;18:1324-1335.e2. doi:10.1016/j.cgh.2020.02.009

  17. Grillo TG, Silveira CF, Quaglio AV, Dutra R, et. al. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature. World J Cardiol. 2023;15(5):217-228. doi:10.4330/wjc.v15.i5.217

  18. Medline Plus. Azathioprine.

  19. Gade AK, Douthit NT, Townsley E. Medical management of Crohn’s disease. Cureus. 2020;12:e8351. doi:10.7759/cureus.8351

  20. Crohns & Colitis. Crohn's disease symptoms.

  21. Ye BD, Hong SN, Seo SI, et al. Changes in the long-term prognosis of Crohn's disease between 1986 and 2015: the population-based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study. Gut Liver. 2022;16:216-227. doi:10.5009/gnl210044

Amber J. Tresca

By Amber J. Tresca
Tresca is a writer and speaker who covers digestive conditions, including IBD. She was diagnosed with ulcerative colitis at age 16.